90 related articles for article (PubMed ID: 3661533)
1. The influence of exogenous estrogen use on survival after diagnosis of endometrial cancer.
Schwartzbaum JA; Hulka BS; Fowler WC; Kaufman DG; Hoberman D
Am J Epidemiol; 1987 Nov; 126(5):851-60. PubMed ID: 3661533
[TBL] [Abstract][Full Text] [Related]
2. Oestrogen use and survival in endometrial cancer.
Collins J; Donner A; Allen LH; Adams O
Lancet; 1980 Nov; 2(8201):961-4. PubMed ID: 6107599
[TBL] [Abstract][Full Text] [Related]
3. Prognostic features of endometrial cancer in estrogen users and obese women.
La Vecchia C; Franceschi S; Gallus G; Decarli A; Colombo E; Liberati A; Tognoni G
Am J Obstet Gynecol; 1982 Oct; 144(4):387-90. PubMed ID: 7124857
[TBL] [Abstract][Full Text] [Related]
4. Changing trends and prognostic features in endometrial cancer associated with exogenous estrogen therapy.
Robboy SJ; Bradley R
Obstet Gynecol; 1979 Sep; 54(3):269-77. PubMed ID: 471366
[TBL] [Abstract][Full Text] [Related]
5. Survival among women with endometrial cancer: a comparison of estrogen users and nonusers.
Chu J; Schweid AI; Weiss NS
Am J Obstet Gynecol; 1982 Jul; 143(5):569-73. PubMed ID: 7091228
[TBL] [Abstract][Full Text] [Related]
6. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases.
Spengler RF; Clarke EA; Woolever CA; Newman AM; Osborn RW
Am J Epidemiol; 1981 Oct; 114(4):497-506. PubMed ID: 7304580
[TBL] [Abstract][Full Text] [Related]
7. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
Obrink A; Bunne G; Collén J; Tjernberg B
Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
[TBL] [Abstract][Full Text] [Related]
8. Endometrial carcinoma: histopathology, survival, and exogenous estrogens.
Smith DC; Prentice RL; Bauermeister DE
Gynecol Obstet Invest; 1981; 12(4):169-79. PubMed ID: 7250780
[TBL] [Abstract][Full Text] [Related]
9. Endometrial cancer and estrogen use. Report of a large case-control study.
Antunes CM; Strolley PD; Rosenshein NB; Davies JL; Tonascia JA; Brown C; Burnett L; Rutledge A; Pokempner M; Garcia R
N Engl J Med; 1979 Jan; 300(1):9-13. PubMed ID: 213722
[TBL] [Abstract][Full Text] [Related]
10. Influence of Body Mass Index on Tumor Pathology and Survival in Uterine Cancer: A Danish Register Study.
Kristensen AB; Hare-Bruun H; Høgdall CK; Rudnicki M
Int J Gynecol Cancer; 2017 Feb; 27(2):281-288. PubMed ID: 27922975
[TBL] [Abstract][Full Text] [Related]
11. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
[TBL] [Abstract][Full Text] [Related]
12. Carcinoma of the endometrium.
Cavanagh D; Marsden DE; Ruffolo EH
Obstet Gynecol Annu; 1984; 13():211-60. PubMed ID: 6371616
[TBL] [Abstract][Full Text] [Related]
13. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
[TBL] [Abstract][Full Text] [Related]
14. [Postmenopausal estrogen and endometrial neoplasms].
Bengtsson LP
Lakartidningen; 1979 May; 76(19):1801-2. PubMed ID: 439977
[TBL] [Abstract][Full Text] [Related]
15. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
16. Protection against endometrial carcinoma by combination-product oral contraceptives.
Hulka BS; Chambless LE; Kaufman DG; Fowler WC; Greenberg BG
JAMA; 1982 Jan 22-29; 247(4):475-7. PubMed ID: 7033575
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for uterine cancer in reproductive-aged women.
Lee NK; Cheung MK; Shin JY; Husain A; Teng NN; Berek JS; Kapp DS; Osann K; Chan JK
Obstet Gynecol; 2007 Mar; 109(3):655-62. PubMed ID: 17329517
[TBL] [Abstract][Full Text] [Related]
18. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
19. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
20. Conjugated estrogen use and risk of endometrial cancer.
Buring JE; Bain CJ; Ehrmann RL
Am J Epidemiol; 1986 Sep; 124(3):434-41. PubMed ID: 3017100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
